OpenLegislation

Division 12 Box 16:F1

United Kingdom

Original text. Later amendments are not shown.

  • Indicate in block letters the name of the applicant or, where appropriate, of his authorised representative who signs this application.

  • The signature by the applicant or his authorised representativeF2... indicates that the person concerned is declaring that all the particulars provided on the application are correctly and fully stated. Without prejudice to the possible application of penal provisions, this declaration is equivalent to the engagement of responsibility, under the provisions in force ..., in respect of the following:

    • the accuracy of the information;

    • the authenticity of any documents attached;

    • the observance of all other obligations.

  • Whenever the authorisation is issued by means of a computerised procedure, that authorisation may not contain the signature of the applicant in this box, if the application as such contains such signature.

Annotations

Textual amendments

F1

Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.

F2

Words in Annex 4 Form notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(iv); 2020 c. 1, Sch. 5 para. 1(1)

Notes on Annex IV

Textual amendments

F2

Annex 4 Form heading: words “UNITED KINGDOM” substituted for “EUROPEAN UNION” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)

F3

Annex 4 Form box 9: words “United Kingdom” substituted for “customs territory of the Union” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)

F4

Annex 4 Form heading: words “European Union or Great Britain” substituted for “UNITED KINGDOM” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(8)(a)(i)

F5

Annex 4 Form box 9: words “Great Britain/the customs territory of the Union” substituted for “the United Kingdom” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(8)(a)(ii)